Allarity Therapeutics (ALLR) EPS (Basic) (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly EPS (Basic) came in at -$0.17 in Q1 2026, up 29.63% YoY from -$0.13 in Q1 2025, and up 26.48% on a QoQ basis from -$0.23 in Q4 2025.
Allarity Therapeutics (ALLR) EPS (Basic) (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of EPS (Basic) data on file, last reported at -$0.17 in Q1 2026.
- Quarterly EPS (Basic) rose 29.63% year-over-year to -$0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.7 (up 67.28% YoY) and the FY2025 annual result came in at -$0.78, up 95.01% from the prior year.
- EPS (Basic) grew to -$0.17 in Q1 2026, from -$0.23 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.15 in Q2 2025 to a low of -$589090.9 in Q2 2022.
- A 5-year average of -$118611.0 and a median of -$518.99 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 271.0% — and 2024, when it surged 99.98%.
- Tracing ALLR's EPS (Basic) over 5 years: stood at -$282000.0 in 2022, then surged by 99.82% to -$518.99 in 2023, then jumped by 99.11% to -$4.64 in 2024, then surged by 94.94% to -$0.23 in 2025, then grew by 26.48% to -$0.17 in 2026.
- The last three EPS (Basic) figures came in at -$0.17 (Q1 2026), -$0.23 (Q4 2025), and -$0.19 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | -0.23 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -4.64 |
| Sep 30, 2024 | -7.71 |
| Jun 30, 2024 | -3.34 |
| Mar 31, 2024 | -664.16 |
| Dec 31, 2023 | -518.99 |
| Sep 30, 2023 | -1,346.27 |
| Jun 30, 2023 | -15,758.45 |
| Mar 31, 2023 | -104,875.00 |
| Dec 31, 2022 | -282,000.00 |
| Sep 30, 2022 | -556,916.67 |
| Jun 30, 2022 | -589,090.91 |
| Mar 31, 2022 | -465,200.00 |
| Dec 31, 2021 | -2.10 Mn |
| Sep 30, 2021 | -150,111.11 |
| Jun 30, 2021 | -899,333.33 |